Acorda Therapeutics

-$0.20 (-5.06%) Today
-$0.05 (-1.33%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACOR and other ETFs, options, and stocks.

About ACOR

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene).

CEO
Ronald Cohen
Employees
168
Headquarters
Ardsley, New York
Founded
1995

ACOR Key Statistics

Market Cap
35.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.69M
High Today
$4.00
Low Today
$3.70
Open Price
$3.88
Volume
451.19K
52 Week High
$9.84
52 Week Low
$2.53

ACOR Earnings

-$2.54
-$1.69
-$0.85
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure